From: Rule-based multi-scale simulation for drug effect pathway analysis
Drug A | Drug B | Drug development State |
---|---|---|
Metformin | Saxagliptin | FDA approved |
Metformin | Sitagliptin | FDA approved |
Metformin | Vildagliptin | FDA approved |
Metformin | Miglitol | Literature [26] |
Metformin | Voglibose | FDA approved |
Metformin | Liraglutide | Phase 3 |
Metformin | Mitiglinide | Phase 3 |
Metformin | Nateglinide | Literature [27] |
Metformin | Repaglinide | FDA approved |
Metformin | Glipizide | FDA approved |
Metformin | Gliquidone | Literature [28] |
Metformin | Glimepiride | FDA approved |
Metformin | Glyburide | FDA approved |
Metformin | Pioglitazone | FDA approved |
Metformin | Rosiglitazone | FDA approved |